2017
Risk/Benefit Discussion of Alcohol Use Disorder Medications: Behavioral Economic Considerations and General Recommendations
Santana T, Greenwald M, Rosen M. Risk/Benefit Discussion of Alcohol Use Disorder Medications: Behavioral Economic Considerations and General Recommendations. Journal Of Addiction Research & Therapy 2017, 8: 1-8. DOI: 10.4172/2155-6105.1000315.Peer-Reviewed Original ResearchRisk/benefit discussionAlcohol use disorderAUD medicationsBenefit discussionInteroceptive effectsAlcohol use disorder medicationsAlcohol useBehavioral economic principlesRisk/benefitReduced alcohol usePrescribers' practicesMedication risksEffective medicationsPatients' perceptionsPatient acceptanceMedicationsUse disordersCognitive dissonancePatientsPsychological stateNarrative thinkingBiased decisionsRiskHalo effectFormulation of guidelines
2012
Association Between Use of Specific Drugs and Antiretroviral Adherence: Findings from MACH 14
Rosen MI, Black AC, Arnsten JH, Goggin K, Remien RH, Simoni JM, Golin CE, Bangsberg DR, Liu H. Association Between Use of Specific Drugs and Antiretroviral Adherence: Findings from MACH 14. AIDS And Behavior 2012, 17: 142-147. PMID: 22246513, PMCID: PMC3549004, DOI: 10.1007/s10461-011-0124-7.Peer-Reviewed Original Research
2001
Consumer Experience with Payeeship Provided by a Community Mental Health Center
Rosen M, Desai R, Bailey M, Davidson L, Rosenheck R. Consumer Experience with Payeeship Provided by a Community Mental Health Center. Psychiatric Rehabilitation Journal 2001, 25: 190-195. PMID: 11769986, DOI: 10.1037/h0095025.Peer-Reviewed Original ResearchConceptsCommunity mental health centerTherapeutic allianceMental health centersWeaker therapeutic allianceStrong therapeutic allianceMost patientsWorking Alliance InventoryHealth centersDifferent staff membersAlliance InventoryAlliance scoresClinical therapistsSignificant minorityPatientsOverall satisfactionFeelings of coercionStaff membersMoney management servicesTherapists
1999
Interactions of Cocaine with Nimodipine: A Brief Report
Kosten T, Woods S, Rosen M, Pearsall H. Interactions of Cocaine with Nimodipine: A Brief Report. American Journal On Addictions 1999, 8: 77-81. PMID: 10189518, DOI: 10.1080/105504999306117.Peer-Reviewed Original Research
1997
Recurrent personal memories during intoxication reported by patients with alcoholism
HOFFMAN R, ESPOSITO R, ROSEN M, ROCKHOLZ P. Recurrent personal memories during intoxication reported by patients with alcoholism. Psychological Medicine 1997, 27: 1441-1446. PMID: 9403915, DOI: 10.1017/s0033291797005400.Peer-Reviewed Original ResearchConceptsPersonal memoriesState-dependent effectsAlcoholic patientsRecurrent memoriesMemory phenomenaSelective retrievalComparison conditionSemi-structured interviewsMemoryAlcohol useComparison groupDisturbing eventsCocaine-abusing patientsPatientsElicit informationIntoxicationFurther studiesLearningRetrievalInterviewsExperienceCocaineEffects of gamma-hydroxybutyric acid (GHB) in opioid-dependent patients
Rosen M, Pearsall H, Woods S, Kosten T. Effects of gamma-hydroxybutyric acid (GHB) in opioid-dependent patients. Journal Of Substance Use And Addiction Treatment 1997, 14: 149-154. PMID: 9258859, DOI: 10.1016/s0740-5472(96)00157-2.Peer-Reviewed Original ResearchTreatment of Early AIDS Dementia in Intravenous Drug Users: High Versus Low Dose Peptide T
Kosten T, Rosen M, McMahon T, Bridge T, O'malley S, Pearsall R, O'connor P. Treatment of Early AIDS Dementia in Intravenous Drug Users: High Versus Low Dose Peptide T. The American Journal Of Drug And Alcohol Abuse 1997, 23: 543-553. PMID: 9366972, DOI: 10.3109/00952999709016894.Peer-Reviewed Original ResearchDose Dependent Effects of Yohimbine on Methadone Maintained Patients
Hameedi F, Woods S, Rosen M, Pearsall H, Kosten T. Dose Dependent Effects of Yohimbine on Methadone Maintained Patients. The American Journal Of Drug And Alcohol Abuse 1997, 23: 327-333. PMID: 9143642, DOI: 10.3109/00952999709040950.Peer-Reviewed Original Research
1994
SPECT regional cerebral blood flow alterations in naltrexone-precipitated withdrawal from buprenorphine
van Dyck C, Rosen M, Thomas H, McMahon T, Wallace E, O'Connor P, Sullivan M, Krystal J, Hoffer P, Woods S, Kosten T. SPECT regional cerebral blood flow alterations in naltrexone-precipitated withdrawal from buprenorphine. Psychiatry Research 1994, 55: 181-191. PMID: 7701033, DOI: 10.1016/0925-4927(94)90013-2.Peer-Reviewed Original ResearchConceptsRegional cerebral blood flowRegional cerebral blood flow alterationsCerebral blood flow alterationsHexamethyl propylene amine oximeOpiate-induced analgesiaBlood flow alterationsSeverity of withdrawalCerebral blood flowOpiate-dependent patientsAnterior cingulate regionsAnterior cingulate cortexSingle photon emissionPlacebo administrationAmine oximeOpiate withdrawalRCBF ratiosWithdrawal severityBlood flowCingulate cortexCingulate regionsSignificant negative correlationBuprenorphineNaltrexonePlaceboPatientsBuprenorphine: duration of blockade of effects of intramuscular hydromorphone
Rosen M, Wallace E, McMahon T, Pearsall H, Woods S, Price L, Kosten T. Buprenorphine: duration of blockade of effects of intramuscular hydromorphone. Drug And Alcohol Dependence 1994, 35: 141-149. PMID: 7519977, DOI: 10.1016/0376-8716(94)90121-x.Peer-Reviewed Original Research
1993
Carbamazepine vs. Oxazepam for Benzodiazepine Detoxification in Methadone‐Maintained Patients
Rosen M, Pearsall H, Price L, McDougle C, Woods S, Kosten T. Carbamazepine vs. Oxazepam for Benzodiazepine Detoxification in Methadone‐Maintained Patients. American Journal On Addictions 1993, 2: 165-168. DOI: 10.1111/j.1521-0391.1993.tb00217.x.Peer-Reviewed Original Research
1992
Peptide T Treatment of Cognitive Impairment in HIV‐Positive Intravenous Drug Users
Rosen M, Bridge T, O'Malley S, Pearsall H, Martini B, O'Connor P, Brett‐Smith H, Thomas H, Van Dyck C, Woods S, Kosten T. Peptide T Treatment of Cognitive Impairment in HIV‐Positive Intravenous Drug Users. American Journal On Addictions 1992, 1: 332-338. DOI: 10.1111/j.1521-0391.1992.tb00359.x.Peer-Reviewed Original ResearchHIV-positive intravenous drug usersDouble-blind crossover studyPeptide T treatmentHIV-positive patientsPeptide TOpen clinical trialIntravenous drug usersVasoactive intestinal peptideAIDS dementiaCrossover studyNeuropsychological improvementAZT treatmentIntestinal peptideClinical trialsDrug usersCognitive impairmentPatientsNeuropsychological functionCognitive functionT treatmentPlaceboThree timesWeeksPotential utilityTreatmentCocaine-Associated Panic Attacks in Methadone-Maintained Patients
Rosen M, Kosten T. Cocaine-Associated Panic Attacks in Methadone-Maintained Patients. The American Journal Of Drug And Alcohol Abuse 1992, 18: 57-62. PMID: 1314016, DOI: 10.3109/00952999209001611.Peer-Reviewed Original Research